Slovak Republic vs Tunisia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Slovak Republic
96.0%
in 2025
Tunisia
96.0%
in 2025
Slovak Republic rank
27th
Tunisia rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Slovak Republic
- Tunisia
How they compare
Slovak Republic currently reports 96.0% against 96.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tunisia ahead.
Slovak Republic ranks 27th and Tunisia ranks 27th of 194 countries.
Slovak Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Slovak Republic | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.5% | 0.0% | 49.5% | Slovak Republic |
| 2010s | 97.3% | 0.0% | 97.3% | Slovak Republic |
| 2020s | 96.2% | 95.2% | 1.0% | Slovak Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Slovak Republic or Tunisia?
- Slovak Republic, at 96.0% against 96.0% in Tunisia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Slovak Republic and Tunisia?
- 0.0%, with Slovak Republic ahead.
- How many years of comparable data are there for Slovak Republic and Tunisia?
- 18 years are reported by both, from 2008 to 2025.
- How do Slovak Republic and Tunisia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Slovak Republic ranks 27th and Tunisia ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.